Stoke Therapeutics(STOK) - 2026 Q3 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2026 45 Wiggins Ave Bedford, Massachusetts 01730 (Address of principal executive offices) (Zip Code) (I.R.S. Employer Identification No.) (781) 430-8200 (Registrant's telephone number, including area code) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE A ...

Stoke Therapeutics(STOK) - 2026 Q3 - Quarterly Report - Reportify